University Hospital Schleswig-Holstein, Campus Kiel
Welcome,         Profile    Billing    Logout  
 26 Trials 
43 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hill, Michael D
PLATINUM, NCT04443608: Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management

Terminated
4
115
US
Patiromer Powder for Oral Suspension [Veltassa], Active drug, Placebo, Inactive substance
Comprehensive Research Associates
Hyperkalemia
03/23
06/23
ESCAPE-NEXT, NCT04462536 / 2020-002360-30: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Completed
3
850
Europe, Canada, US, RoW
Placebo, Nerinetide, NA-1
NoNO Inc., University of Calgary
Stroke, Acute
08/23
08/23
ACT-WHEN, NCT06320431: ACT-GLOBAL THROMBOLYSIS (-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Recruiting
3
4000
Canada, RoW
Tenecteplase, TNKase, Metalyse
University of Calgary, The George Institute for Global Health, Australia
Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic
09/30
12/30
ACT-GLOBAL, NCT06352632: Adaptive Platform Trial for Stroke

Recruiting
3
20000
Canada, RoW
Standard-dose intravenous tenecteplase, Low-dose intravenous tenecteplase, No intravenous tenecteplase, Conservative Blood Pressure Control, Moderate Blood Pressure Control, Intensive Blood Pressure Control, Placebo, NoNO-42, No deferoxamine mesylate and no colchicine, Deferoxamine mesylate only, Colchicine only, Both deferoxamine mesylate and colchicine
The George Institute, University of Calgary, Berry Consultants
Stroke
09/34
09/34
TEMPO-2, NCT02398656: A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

Completed
3
1274
Europe, Canada, RoW
Tenecteplase, TNK-tPA, Antiplatelet treatment, ASA, Clopidogrel
University of Calgary
Stroke, Acute
01/24
04/24
ENDOLOW, NCT04167527: Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting
2/3
200
Europe, Canada, US
Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device, EmboTrap III, Initial medical management (iMM)
Emory University, University of Calgary, University of Cincinnati, Heidelberg University, Children's Hospital Medical Center, Cincinnati
Cerebral Ischemia
12/24
12/24
NCT05123755: Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

Recruiting
2a
120
US
AV-001 Injection, AV-001 Placebo Injection
Vasomune Therapeutics, Inc.
Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia, Pneumonia, Viral, Respiratory Infection, COVID-19 Acute Respiratory Distress Syndrome
12/24
03/25
KOURAGE, NCT06374797: A Study of Auxora in Patients with AKI and Injurious Lung "Crosstalk"

Recruiting
2
150
US
Auxora, Placebo
CalciMedica, Inc.
Acute Kidney Injury
08/25
08/25
RAISE, NCT06226805: Study of BB-031 in Acute Ischemic Stroke Patients

Recruiting
2
156
US, RoW
BB-031, DTRI-031, Placebo, Saline
Basking Biosciences, Inc.
Acute Ischemic Stroke
12/26
03/27
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS

Completed
2
216
US, RoW
CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo
CalciMedica, Inc.
Acute Pancreatitis, Systemic Inflammatory Response Syndrome
05/24
05/24
NCT06403267: NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis with or Without Endovascular Thrombectomy

Recruiting
2
600
Canada
NoNO-42, Placebo, Control
NoNO Inc.
Acute Ischemic Stroke
05/26
05/26
ACST-2, NCT00883402: Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients

Active, not recruiting
N/A
3638
Europe, Canada, Japan, US, RoW
CEA, CAS
University of Oxford, NHS Health Technology Assessment Programme, BUPA Foundation, British Heart Foundation
Carotid Stenosis
12/20
12/25
Tension, NCT03094715: Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window

Terminated
N/A
253
Europe, Canada, RoW
Thrombectomy, Mechanical thrombectomy, Best medical care, Control group
University Hospital Heidelberg, Karolinska University Hospital, Eppdata GmbH Hamburg, Germany, Aarhus University Hospital, Medical University Innsbruck, Groupe Hospitalier Pitie-Salpetriere, Oslo University Hospital, University Hospital, Martin, Charles University, Czech Republic, Hospices Civils de Lyon, CHU de Reims, Epidemiological and Clinical Research Information Network, STROKE ALLIANCE FOR EUROPE, International Consortium for Health Outcome Measurement, Inc., Europan Society for Minimally Invasive Neurological Therapy, Universitätsklinikum Hamburg-Eppendorf
Stroke, Acute, Cerebral Stroke, Cerebrovascular Stroke, Apoplexy; Brain
05/23
11/23
ENCHANTED3/MT, NCT06352619: Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial

Recruiting
N/A
2000
Canada, RoW
Conservative SBP Control, Moderate SBP Control, Intensive SBP Control
The George Institute, University of Calgary, Changhai Hospital
Ischemic Stroke, Acute
05/26
05/26
Koch, Andrea
MYOFLAME-19, NCT05619653: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Recruiting
3
280
Europe
Prednisolone, Losartan
Valentina Puentmann, Bayer, Alcedis GmbH
COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina
12/24
12/28
VISTA, NCT05797519: Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

Recruiting
N/A
40
Europe, RoW
VDyne Transcatheter Tricuspid Valve Replacement System, VDyne System, VDyne Tricuspid System, VDyne Valve System, VDyne Valve
VDyne, Inc.
Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valvular Disorders
09/25
09/29
Bein, Berthold
HERO-19, NCT04542408: Hamburg Edoxaban for Anticoagulation in COVID-19 Study

Completed
3
140
Europe
Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or Placebo
Universitätsklinikum Hamburg-Eppendorf
Covid19
09/22
01/23
NCT04260789: Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection

Recruiting
N/A
232
Europe
Seraph 100,The Microbind Affinity Blood Filter
ExThera Medical Europe BV, ExThera Medical Corporation, Vivantes Klinikum Neukölln
Bloodstream Infection
03/22
08/22
Ellrichmann, Mark
NCT02631798: Chromocolonoscopy With Food-grade Dyes

Recruiting
N/A
30
Europe
Food grade dye mucosal staining
University Hospital Schleswig-Holstein
Chromoendoscopy
06/23
07/23
PROTOCOL, NCT05817721: PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents

Recruiting
N/A
639
Europe
Proton pump inhibitor, LAMS-implantation
University Medical Center Goettingen, Technical University of Munich, Ludwig-Maximilians - University of Munich, University Hospital in Halle, University of Leipzig, University Hospital Heidelberg, Landesklinikum Sankt Polten, University Hospital Schleswig-Holstein, St. Josef Hospital Bochum, Klinikum Stadt Hanau, University Hospital, Aachen, University Hospital Regensburg
Acute Pancreatitis
12/23
12/23
Jansen, Olav
ESCAPE-NEXT, NCT04462536 / 2020-002360-30: Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Completed
3
850
Europe, Canada, US, RoW
Placebo, Nerinetide, NA-1
NoNO Inc., University of Calgary
Stroke, Acute
08/23
08/23
TECNO, NCT05499832: Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

Recruiting
3
156
Europe
Tenecteplase
Insel Gruppe AG, University Hospital Bern
Ischemic Stroke
07/25
10/25
ENDOLOW, NCT04167527: Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting
2/3
200
Europe, Canada, US
Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device, EmboTrap III, Initial medical management (iMM)
Emory University, University of Calgary, University of Cincinnati, Heidelberg University, Children's Hospital Medical Center, Cincinnati
Cerebral Ischemia
12/24
12/24
DISTALS, NCT05152524: Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

Recruiting
N/A
168
Europe, US
Tigertriever 13
Rapid Medical
Ischemic Stroke, Neovascularization
03/25
03/25
Schreiber, Stefan
VECTORS, NCT06257706: - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Recruiting
4
304
Europe, Canada, US, RoW
Vedolizumab
Alimentiv Inc., Takeda
Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
01/27
09/28
FRESCO, NCT03843385: Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis

Recruiting
3
174
Europe
encapsulated faecal microbiota filtrate, FMFT, encapsulated faecal microbiota, FMT, Placebo, Encapsulated sterile saline
Andreas Stallmach, German Federal Ministry of Education and Research
Ulcerative Colitis, Inflammatory Bowel Diseases
01/25
07/26
ABX464-105, NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Recruiting
3
612
Europe, Canada, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25
VIVID-2, NCT04232553 / 2019-002687-27: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Recruiting
3
778
Europe, Canada, Japan, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company
Crohn's Disease
11/24
12/26
ABTECT, NCT05535946: - Maintenance

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
NCT06488625: Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients with Mild to Moderately Active Ulcerative Colitis

Recruiting
2/3
459
Europe
Low-Dose CICR-NAM, High-Dose CICR-NAM, 0 g/d CICR-NAM (blinded), Open-Label
University Hospital Schleswig-Holstein, Ced Service GmbH, Gesellschaft für Therapieforschung mbH, German Federal Ministry of Education and Research
Ulcerative Colitis, Unspecified
10/27
12/27
NCT04781543 / 2020-005764-62: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

Jan 2024 - Dec 2024: Data from trial for diffuse cutaneous systemic sclerosis
Active, not recruiting
2/3
301
Europe, Japan, US, RoW
HZN-825 BID, Placebo, HZN-825 QD
Amgen, Horizon Therapeutics USA, Inc
Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic
09/25
09/25
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Recruiting
2
268
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Crohn's Disease
09/26
07/27
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting
2
207
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Ulcerative Colitis
09/26
08/27
NCT02631798: Chromocolonoscopy With Food-grade Dyes

Recruiting
N/A
30
Europe
Food grade dye mucosal staining
University Hospital Schleswig-Holstein
Chromoendoscopy
06/23
07/23
ImmUniverse, NCT05456893: A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies

Recruiting
N/A
95
Europe
Procedure: endoscopic biopsy, Blood sampling, stool sampling
Central Hospital, Nancy, France
Ulcerative Colitis, Inflammatory Bowel Diseases
12/24
09/27
NAPKON-POP, NCT04679584: COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life

Recruiting
N/A
2000
Europe
Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital, German Federal Ministry of Education and Research
COVID-19
12/21
12/30
Bahmer, Thomas J
ALLIANCE, NCT02419274: Adult Arm of DZL All Age Asthma Cohort

Recruiting
N/A
400
Europe
LungenClinic Grosshansdorf, German Center for Lung Research, Research Center Borstel
Asthma
12/25
12/30
NAPKON-POP, NCT04679584: COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life

Recruiting
N/A
2000
Europe
Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital, German Federal Ministry of Education and Research
COVID-19
12/21
12/30
Wolfgang, Lieb
NAPKON-POP, NCT04679584: COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life

Recruiting
N/A
2000
Europe
Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital, German Federal Ministry of Education and Research
COVID-19
12/21
12/30
Michael, Krawczak
NAPKON-POP, NCT04679584: COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life

Recruiting
N/A
2000
Europe
Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital, German Federal Ministry of Education and Research
COVID-19
12/21
12/30
Hermes, Anne
NAPKON-POP, NCT04679584: COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life

Recruiting
N/A
2000
Europe
Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings
University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital, German Federal Ministry of Education and Research
COVID-19
12/21
12/30
Frank, Johanne
MYOFLAME-19, NCT05619653: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Recruiting
3
280
Europe
Prednisolone, Losartan
Valentina Puentmann, Bayer, Alcedis GmbH
COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina
12/24
12/28
Voges, Inga
MYOFLAME-19, NCT05619653: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Recruiting
3
280
Europe
Prednisolone, Losartan
Valentina Puentmann, Bayer, Alcedis GmbH
COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina
12/24
12/28

Download Options